Has anyone seen successful implementation of this insidious tool in the pharmaceutical industry or is it always as destructive as it has been at AstraZeneca? i.e. a scam for cost cutting, reduction of headcount and general demoralisation. I guess our auspicious team of Black and Green belts may disagree, but then they would, but the damage it has done to the 99% of other employees can't possibly be worth it. I'm sure that there is some place for it in the world, but maybe not here.
Submitted by Anonymous on Mon, 26/09/2011 - 23:40